Wedbush Securities’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-615
| Closed | -$150K | – | 1003 |
|
|
2020
Q3 | $150K | Sell |
615
-126
| -17% | -$30.7K | 0.01% | 793 |
|
|
2020
Q2 | $213K | Buy |
741
+221
| +43% | +$63.5K | 0.02% | 754 |
|
|
2020
Q1 | $106K | Buy |
520
+134
| +35% | +$27.3K | 0.01% | 765 |
|
|
2019
Q4 | $173K | Sell |
386
-5
| -1% | -$2.24K | 0.02% | 884 |
|
|
2019
Q3 | $120K | Sell |
391
-19
| -5% | -$5.83K | 0.01% | 884 |
|
|
2019
Q2 | $130K | Sell |
410
-16
| -4% | -$5.07K | 0.01% | 877 |
|
|
2019
Q1 | $179K | Buy |
+426
| New | +$179K | 0.02% | 801 |
|
|
2018
Q2 | – | Sell |
-645
| Closed | -$191K | – | 914 |
|
|
2018
Q1 | $191K | Buy |
+645
| New | +$191K | 0.02% | 696 |
|
|
2017
Q4 | – | Sell |
-345
| Closed | -$114K | – | 909 |
|
|
2017
Q3 | $114K | Buy |
+345
| New | +$114K | 0.01% | 770 |
|
|
2016
Q1 | – | Sell |
-38
| Closed | -$25K | – | 808 |
|
|
2015
Q4 | $25K | Hold |
38
| – | – | ﹤0.01% | 709 |
|
|
2015
Q3 | $18K | Buy |
38
+7
| +23% | +$3.32K | ﹤0.01% | 701 |
|
|
2015
Q2 | $18K | Buy |
+31
| New | +$18K | ﹤0.01% | 711 |
|